Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/29/2025

Paroxetine and Dapoxetine for Premature Ejaculation

Efficacy of PRN Dosing vs Daily Dosing

  • The European Association of Urology states that on-demand administration of off-label SSRIs provides substantially less ejaculatory delay than daily treatment in most studies 2
  • Daily paroxetine 20 mg increases intravaginal ejaculatory latency time (IELT) by approximately 8.8-fold, making it the preferred off-label SSRI for premature ejaculation 2

Dosing Considerations for PRN Use

  • The recommended approach for PRN dosing is to start with daily paroxetine 10-20 mg for 14-21 days to achieve steady-state levels, then switch to PRN dosing of 20 mg taken 3-4 hours before planned sexual activity 1
  • The 10 mg PRN dose is below the evidence-based PRN dose of 20 mg used in clinical trials 1

Alternative: Dapoxetine for True PRN Therapy

  • Dapoxetine 30 mg taken 1-3 hours before sexual activity is recommended as first-line treatment by the European Association of Urology 2
  • In patients with baseline IELT <30 seconds, dapoxetine 30 mg improves IELT by 3.4-fold 2

Safety Profile and Side Effects

  • The FDA label confirms that ejaculatory disturbance occurs in 13-28% of males taking paroxetine, though this is the desired therapeutic effect in PE treatment 2
  • Do not combine paroxetine with MAOIs due to serotonin syndrome risk 2
  • Avoid abrupt discontinuation of daily-dosed SSRIs to prevent withdrawal syndrome 2

Practical Algorithm for Treatment Selection

  • The American Urological Association and European Association of Urology recommend daily paroxetine 20 mg (or start at 10 mg and titrate up) for maximum efficacy 1, 2
  • If daily dosing is unacceptable to the patient, consider dapoxetine 30 mg PRN if available in your country 2

REFERENCES

1

SSRI Treatment for Premature Ejaculation: Dapoxetine 30mg PRN [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025